Vimarsana
Biggest News Aggregation in the World

Page 31 - Trials Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trials Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trials Network Today - Breaking & Trending Today

Woman From the U.S. Cured of HIV Using a Revolutionary Treatment for Leukemia - Vimarsana News

Woman From the U.S. Cured of HIV Using a Revolutionary Treatment for Leukemia

A third person was reportedly cured of HIV after receiving a bone marrow using umbilical cord blood stem cell treatment for leukemia.

First-Ever Woman Cured From HIV After Successful Stem Cell Transplant - Vimarsana News

First-Ever Woman Cured From HIV After Successful Stem Cell Transplant

An unknown American lady was identified with HIV 10 years ago. She confronted anti-retroviral medications, just like hundreds and hundreds of patients who show symptoms in the United States annually, to protect the infection from decimating her inflammatory response. However, that is no longer the situation today.

American Woman Appears to Be Entirely Cured of HIV After Unique Medical Treatment - Vimarsana News

American Woman Appears to Be Entirely Cured of HIV After Unique Medical Treatment

Ten years ago, an unnamed American woman was diagnosed with HIV. Like the tens of thousands of people who test positive in the US each year, she faced a lifetime of anti-retroviral therapies to keep the virus from obliterating her immune system.

Amita Gupta Named Director of Johns Hopkins Medicine's Division of Infectious Diseases – India Education | Latest Education News | Global Educational News - Vimarsana News

Amita Gupta Named Director of Johns Hopkins Medicine's Division of Infectious Diseases – India Education | Latest Education News | Global Educational News

Amita Gupta, M.D., M.H.S., an expert in the global treatment, prevention and control of diseases such as acquired immunodeficiency syndrome (AIDS) and tuberculosis (TB), has been named as the seventh director of Johns Hopkins Medicine’s Division of I

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial - Vimarsana News

Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial

Zacchaeus Anywaine and co-workers study safety and immunogenicity of an Ebola vaccine among children and adolescents across four African countries.

Source: plos.org